comparemela.com
Home
Live Updates
Secondary patent for Johnson & Johnson TB drug rejected: How this will help in Indias fight against tuberculosis : comparemela.com
Secondary patent for Johnson & Johnson TB drug rejected: How this will help in India's fight against tuberculosis
The move promises to bring down prices and improve access, assisting India in its mission to eliminate tuberculosis by 2025.
Related Keywords
India
,
South Africa
,
South African
,
Nandita Venkatesan
,
Indian Nandita Venkatesan
,
Phumeza Tisle
,
Narendra Modi
,
Leena Menghaney
,
World Health Organisation
,
Access Campaign
,
Network Of Maharashtra People Living
,
Doctors Without Borders
,
Rajasthan Right To Health
,
Drug Administration
,
How India
,
Maharashtra People Living
,
South African Phumeza
,
How Long Covid
,
Prime Minister Narendra Modi
,
Tb
,
Tuberculosis
,
Medicine
,
Drugs
,
Bedaquiline
,
Ohnson Amp Johnson
,
Drug Resistant
,
Ndian Express
,
Xpress Explained
,
,
comparemela.com © 2020. All Rights Reserved.